Teton Advisors Inc. Has $132,000 Stock Holdings in Accuray Incorporated (NASDAQ:ARAY)

Teton Advisors Inc. lifted its stake in shares of Accuray Incorporated (NASDAQ:ARAYGet Rating) by 14.3% in the 1st quarter, Holdings Channel reports. The fund owned 40,000 shares of the medical equipment provider’s stock after acquiring an additional 5,000 shares during the quarter. Teton Advisors Inc.’s holdings in Accuray were worth $132,000 as of its most recent SEC filing.

Other large investors also recently made changes to their positions in the company. BNP Paribas Arbitrage SA grew its position in Accuray by 430.8% in the fourth quarter. BNP Paribas Arbitrage SA now owns 714,092 shares of the medical equipment provider’s stock valued at $3,406,000 after purchasing an additional 579,561 shares in the last quarter. ProShare Advisors LLC grew its position in Accuray by 66.1% in the fourth quarter. ProShare Advisors LLC now owns 19,691 shares of the medical equipment provider’s stock valued at $95,000 after purchasing an additional 7,838 shares in the last quarter. Bowling Portfolio Management LLC bought a new position in Accuray in the first quarter valued at $51,000. Heartland Advisors Inc. grew its position in Accuray by 0.3% in the first quarter. Heartland Advisors Inc. now owns 3,385,900 shares of the medical equipment provider’s stock valued at $11,207,000 after purchasing an additional 8,800 shares in the last quarter. Finally, Mitsubishi UFJ Kokusai Asset Management Co. Ltd. grew its position in Accuray by 4.7% in the first quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 127,975 shares of the medical equipment provider’s stock valued at $424,000 after purchasing an additional 5,766 shares in the last quarter. Institutional investors own 66.13% of the company’s stock.

Accuray Stock Down 1.3 %

Shares of NASDAQ ARAY opened at $2.24 on Wednesday. The company has a market capitalization of $209.44 million, a P/E ratio of -37.33 and a beta of 1.74. Accuray Incorporated has a 52-week low of $1.70 and a 52-week high of $5.93. The company has a debt-to-equity ratio of 3.23, a quick ratio of 1.00 and a current ratio of 1.68. The company’s 50 day moving average price is $2.32 and its 200-day moving average price is $2.57.

Accuray (NASDAQ:ARAYGet Rating) last issued its quarterly earnings results on Wednesday, August 10th. The medical equipment provider reported ($0.04) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.06) by $0.02. Accuray had a negative net margin of 1.24% and a negative return on equity of 10.61%. During the same period in the prior year, the company posted ($0.01) EPS.

Wall Street Analysts Forecast Growth

A number of research firms recently weighed in on ARAY. B. Riley began coverage on shares of Accuray in a research report on Thursday, June 23rd. They issued a “buy” rating and a $7.50 target price for the company. BTIG Research decreased their price objective on shares of Accuray from $9.00 to $7.00 and set a “buy” rating for the company in a research report on Friday, June 24th. Finally, StockNews.com downgraded shares of Accuray from a “buy” rating to a “hold” rating in a research report on Tuesday, August 16th. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $7.33.

About Accuray

(Get Rating)

Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the Americas, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of various types of cancer and tumors in the body, such as prostate, lung, brain, spine, liver, pancreas, and kidney.

See Also

Want to see what other hedge funds are holding ARAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Accuray Incorporated (NASDAQ:ARAYGet Rating).

Institutional Ownership by Quarter for Accuray (NASDAQ:ARAY)

Receive News & Ratings for Accuray Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Accuray and related companies with MarketBeat.com's FREE daily email newsletter.